Skip to main navigation Skip to search Skip to main content

Retinal biomarkers for Alzheimer’s disease in the prodromal and preclinical population - The Deep and Frequent Phenotyping study

Research output: Contribution to journal › Meeting abstract › peer-review

69 Downloads (Pure)

Abstract

BACKGROUND: Recent challenges for disease-modifying therapies for Alzheimer's disease (AD) highlighted the need for biomarkers in the prodromal and preclinical stages. The Deep and Frequent Phenotyping (DFP) study aims to identify biomarkers for use in proof-of-concept trials. The DFP combines established AD markers with experimental approaches, including multimodal retinal imaging. Here, we report the baseline retinal vascular characteristics from ultra-widefield retinal images and retinal thickness measurements from Optical Coherence Tomography (OCT). 

METHOD: Participants were recruited aged ≥60 years with prodromal AD and control participants in a 4:1 ratio. Retinal vascular parameters (RVPs) were extracted from OPTOS ultrawide-field (UWF) images. Fractal dimension (FD), width gradient (WG), width intercept (WI), and tortuosity (TORT) were measured using the VAMPIRE software. OCT images were segmented with Heidelberg Eye Explorer (Heyex) to acquire the Retinal and Retinal Nerve Fibre Layer (RNFL) thickness. Associations between RVPs and AD risk factors (Family History of Dementia (FHD) and ApoE4 carrier status) were analysed in R, with results reported as medians and interquartile ranges. 

RESULT: FHD (n = 40) demonstrated significantly higher FD (1.13 [1.12, 1.15] vs 1.15 [1.13, 1.15], p <0.01) arterial WI (122μm [110, 132] vs 111μm [102, 129], p <0.05) alongside a lower arterial WG (-3.28μm/mm [-3.87, -2.74] vs -2.90μm/mm [-3.28, -2.35], p <0.05) compared to those without FHD (n = 51). ApoE4 carriers (n = 11) exhibited reduced arteriolar (100μm [94, 115] vs. 115μm [105, 121], p <0.05) and venular (131μm [121, 142] vs. 152μm [136, 159], p <0.05) WI compared to non-carriers (n = 80). No significant associations (p >0.05) were seen between TORT and FHD or ApoE4 status. FHD (n = 41) displayed a trend towards RNFL thickening in the Nasal (77μm [69, 87] vs 82μm [75, 90], p = 0.09) and inferotemporal (137μm [124, 148] vs 149μm [127, 158], p = 0.095) regions, compared to those without FHD (n = 48). No significant trends at baseline were observed between retinal thickness and FHD or ApoE4 status. 

CONCLUSION: These findings suggest that Retinal vascular parameters from OCT and UWF images may serve as non-invasive biomarkers for AD risk, offering a scalable early detection and monitoring method. Future work will focus on longitudinal data to assess trends and their role in tracking disease progression.

Original languageEnglish
Article numbere101540
Number of pages2
JournalAlzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume21
Issue numberS2
DOIs
Publication statusPublished - 25 Dec 2025

Bibliographical note

Publisher Copyright:
© 2025 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alzheimer's disease
  • Dee and Frequent Phenotyping for Alzheimer's disease
  • retinal imaging
  • blood vessels
  • CAA

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Retinal biomarkers for Alzheimer’s disease in the prodromal and preclinical population - The Deep and Frequent Phenotyping study'. Together they form a unique fingerprint.

Cite this